Proceedings from a live event on May 31, 2026, held adjunct with the 2026 ASCO Annual Meeting and moderated by Dr Sara M Tolaney. Published July 2026.
Credit & MOC Details
Credit information is provided by the course provider. We recommend confirming credit eligibility with the provider or your licensing board before starting the activity.
Credit types
AMA PRA Category 1 Credit™Up to 2.25 credits
MOC types
ABS — Accredited CMEUp to 2.25 pointsABIM — Medical KnowledgeUp to 2.25 pointsABS — Self-AssessmentUp to 2.25 points
FDA REMS
No
Qualifies for MIPS
No
Target Specialties
Address:
- 2 South Biscayne Blvd
Pricing
100% of listed courses are free
240 of 240 courses listed here are free.
Collected from the provider’s public pages
Specialties served/covered
- No reviews yet. Be the first to share yours.
Pricing
Free
Reported to ACCME by the provider
- Enduring / On-demand
- Credit · Up to 2.25 credits
- MOC · Up to 2.25 points
-
ReleasedJul 25, 2026
-
Last day to claim creditJul 27, 2027 10 months left
-
Research to Practice Year in Review: Clinical Investigator Perspectives on the Most Relevant New Datasets and Advances in the PI3K/AKT/mTOR Pathway in HR+ mBC | 2026 (Webinar Proceedings)
-
Research to Practice Year in Review: Clinical Investigator Perspectives on the Most Relevant New Datasets and Advances in Oral SERDs for Breast Cancer | 2026 (Webinar Audio Proceedings)
-
Research to Practice What Clinicians Want to Know: Addressing Community Oncologists Questions About the Current and Future Role of ADCs for Breast Cancer | 2026 (Symposium Proceedings)
-
Med Learning Group Emerging Oral SERDs in Early HR+/HER2- Breast Cancer: Biomarkers, Shared Decision-Making, and Practical Management of Investigational Therapies
-
PRIME Education, Inc. (PRIME®) Clinical Evidence at the Edge of Resistance: Next-Generation SERDs for ESR1-Mutated Breast Cancer
-
Physicians’ Education Resource BURST CME(TM) Activity 3: Exploring Combination Strategies in HR+/HER2- MBC: Where Do Oral SERDs Fit In?
